Please assess the completion status of the following clinical trial:

Trial Title: Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy infants as established by medical history and clinical examination before entering the study.~2. Age: 6-8 weeks at the time of enrollment.~3. Parental ability and willingness to provide informed consent.~4. Parent who intends to remain in the area with the child during the study period.~Exclusion Criteria:~1. Presence of diarrhea or vomiting in the previous 72 hours or on the day of enrollment.~2. Acute disease at the time of enrollment (temporary exclusion)~3. Concurrent participation in another clinical trial at any point throughout the entire time frame for this study~4. History of congenital abdominal disorders, intussusception, or abdominal surgery.~5. Known or suspected impairment of immunological function based on medical history and physical examination.~6. History of any neurologic disorders or seizures.~7. Any medical condition in the parents / infant which, in the judgment of the Investigator, would interfere with or serves as a contraindication to protocol adherence or a participant's parents' ability to give informed consent.

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 8 Weeks
- Healthy Volunteers: t

Study Arms:
- LBRV-PV Lot A (Type: EXPERIMENTAL): The study participants in this arm will receive one of the three liquid rotavirus vaccine lots (LBRV-PV Lot A).
- LBRV-PV Lot B (Type: EXPERIMENTAL): The study participants in this arm will receive one of the three liquid rotavirus vaccine lots (LBRV-PV Lot B).
- LBRV-PV Lot C (Type: EXPERIMENTAL): The study participants in this arm will receive one of the three liquid rotavirus vaccine lots (LBRV-PV Lot C).
- ROTASIIL (Type: ACTIVE_COMPARATOR): The study participants in this arm will receive ROTASIIL, the licensed lyophilized rotavirus vaccine in India.

Based on this trial design, predict the completion outcome and termination type (if applicable).